Free Trial
OTCMKTS:CHXIF

Relay Medical (CHXIF) Stock Price, News & Analysis

Notice: This company has been marked as potentially delisted and may not be actively trading.
Today's Range
$0.18
$0.18
50-Day Range
N/A
52-Week Range
$0.16
$0.60
Volume
10,000 shs
Average Volume
955 shs
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
CHXIF stock logo

About Relay Medical Stock (OTCMKTS:CHXIF)

Relay Medical Corp. operates as a medical technology company, which engages in the development of novel medical devices for in vitro diagnostics and point-of-care testing. Its platform technologies include HemoPalm, Pharmatrac, and Osprey. The HemoPalm develops a POCT unit-use cartridge based blood analyzer with full enterprise capabilities. The Pharmatrac is an AI and data analytics driven personal medication management system that addresses the growing problem of non-adherence to treatment. The Osprey, commercializes products and services related to the management of decentralized fleets of medical devices and the data streams they produce. The company was founded by James Samsoondar in 2005 and is headquartered in Toronto, Canada.

CHXIF Stock News Headlines

Henderson set for Crystal Palace medical
West Ham agree deal for Kudus
See More Headlines

Industry, Sector and Symbol

Sector
Medical
Industry
Oil & Gas Production
Sub-Industry
N/A
Current Symbol
OTCMKTS:CHXIF
Previous Symbol
OTCMKTS:MNLIF
CIK
N/A
Web
N/A
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A

Miscellaneous

Free Float
N/A
Optionable
Not Optionable
Beta
N/A

Key Executives

  • Mr. Gerard M. Edwards
    Exec. Chairman
  • Mr. Christopher J. Hopkins CA (Age 55)
    CPA, MBA, Chief Financial Officer
  • Mr. George S. Langdon (Age 60)
    Director
  • Mr. Ashwani Kaushal
    Consultant
  • Mr. Lahav Gil
    CEO & Director

This page (OTCMKTS:CHXIF) was last updated on 5/19/2024 by MarketBeat.com Staff

From Our Partners